- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
Cbl proto-oncogene (CBL) antibody and antigen (Recombinant protein)
Diagnostic Cbl proto-oncogene (CBL) antibodies (anti-Cbl proto-oncogene, anti-CBL) and antigens (recombinant Cbl proto-oncogene (CBL) protein) for Metabolic diseases CBL detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-CBL-Ag01 | Recombinant human CBL/CBL2/RNF55 Protein | 3090 |
| GMP-h-CBL-Ab01 | Anti-human CBL/CBL2/RNF55 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-CBL-Ab02 | Anti-human CBL/CBL2/RNF55 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-CBL-Ab03 | Anti-human CBL/CBL2/RNF55 human monoclonal antibody (mAb) | 1953 |
| GMP-h-CBL-Ab04 | Anti-human CBL/CBL2/RNF55 human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-h-CBL-Ag01 |
| Product Name | Recombinant human CBL/CBL2/RNF55 Protein |
| Target/Biomarker | Cbl proto-oncogene(CBL) |
| Alias of Target/Biomarker | C-CBL, CBL2, FRA11B, NSLL, RNF55 |
| Expression platform | mammalian |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Cbl proto-oncogene (CBL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CBL level test of Metabolic diseases (ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. |
| Products description | Recombinant human CBL/CBL2/RNF55 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-CBL-Ab01, GMP-h-CBL-Ab02 |
| Product Name | Anti-human CBL/CBL2/RNF55 mouse monoclonal antibody (mAb) |
| Target/Biomarker | Cbl proto-oncogene(CBL) |
| Alias of Target/Biomarker | C-CBL, CBL2, FRA11B, NSLL, RNF55 |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human Cbl proto-oncogene (CBL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cbl proto-oncogene (CBL) antibodies in CBL level test of Metabolic diseases (ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human CBL/CBL2/RNF55 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-CBL-Ab03, GMP-h-CBL-Ab04 |
| Product Name | Anti-human CBL/CBL2/RNF55 human monoclonal antibody (mAb) |
| Target/Biomarker | Cbl proto-oncogene(CBL) |
| Alias of Target/Biomarker | C-CBL, CBL2, FRA11B, NSLL, RNF55 |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Human Cbl proto-oncogene (CBL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cbl proto-oncogene (CBL) antibodies in CBL level test of Metabolic diseases (ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human CBL/CBL2/RNF55 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Cystathionine beta-synthase (CBS) is the first enzyme in the transsulfuration pathway, catalyzing the conversion of serine and homocysteine to cystathionine and water. Cystathionine beta-synthase (CBS) deficiency is a rare inherited disorder in the methionine catabolic pathway, in which the impaired synthesis of cystathionine leads to accumulation of homocysteine. Severely affected patients usually present in childhood with ectopia lentis, learning difficulties and skeletal abnormalities.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments